
NASDAQIndustrialsIntegrated Freight & Logistics
Latest quote
$16.78
−$0.57 · -3.29%
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
Regular session
$16.78
−$0.57 · -3.29%
Regular session · ET · Market data may be delayed.
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
Day range
Current $16.78
52-week range
Current $16.78
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
46
Fair Value
Sentiment
70
Bullish
Risk
43
Elevated Risk
Momentum
69
Gaining
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
Day range
Current $16.78
52-week range
Current $16.78
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 176.18M USD | 233.26M USD | 237.28M USD | 222.61M USD | 222.61M USD |
| Cost of goods sold | 93.12M USD | 133.92M USD | 133.4M USD | 126.03M USD | 126.03M USD |
| Gross profit | 83.05M USD | 99.33M USD | 103.87M USD | 96.58M USD | 96.58M USD |
| Research and development | 17.04M USD | 18.04M USD | 15.72M USD | 16.84M USD | 16.84M USD |
| Selling, general, and administrative | 102.82M USD | 146.88M USD | 120.06M USD | 97.56M USD | 97.56M USD |
| Operating expenses | 119.86M USD | 214.49M USD | 135.78M USD | 114.41M USD | 114.41M USD |
| Interest expense | 2.36M USD | 5.5M USD | 6.14M USD | 4.69M USD | 4.69M USD |
| Depreciation and amortization | 27.71M USD | 30.76M USD | 27.49M USD | 22.77M USD | 20.25M USD |
| Operating income | −36.81M USD | −115.16M USD | −31.9M USD | −17.83M USD | −17.83M USD |
| Net income | 78.3M USD | −99.59M USD | −37.33M USD | −275.53M USD | −275.53M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | May 19, 2015 | 1:12 | — | — |
Stock split | Feb 5, 2010 | 1:10 | — | — |
Stock split | Mar 16, 2005 | 8:5 | — | — |
Effective May 19, 2015
1:12
Effective Feb 5, 2010
1:10
Effective Mar 16, 2005
8:5
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI24.38M0.00%2.3T USD0.03%$379.06-0.52%
iShares Russell 2000 ETFIWM22.55M0.03%78.56B USD0.19%$277.5-0.07%
Vanguard Extended Market ETFVXF9.36M0.01%95.4B USD0.05%$232.78-0.31%
Dimensional - US Small Cap ETFDFAS5.46M0.02%33.66B USD0.31%$78.135+0.28%
Schwab U.S. Small-Cap ETFSCHA4.75M0.02%21.7B USD0.03%$32.605-0.02%
Vanguard Russell 2000 ETFVTWO4.55M0.02%18B USD0.06%$112.08-0.12%
Dimensional - US Core Equity 2 ETFDFAC4.45M0.01%88.28B USD0.21%$45.075-0.23%
U.S. Micro Cap Portfolio ETFDFMC2.8M0.04%7.52B USD0.43%$57.48-0.03%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
Dimensional - US Small Cap ETFDFAS
Schwab U.S. Small-Cap ETFSCHA
Vanguard Russell 2000 ETFVTWO
Dimensional - US Core Equity 2 ETFDFAC
U.S. Micro Cap Portfolio ETFDFMCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.